Kimball International, Inc. Reports Second Quarter 2022 Results

<< Back
Kimball International, Inc. Reports Second Quarter 2022 Results

— Strong Demand Drove 11% Revenue Growth; Revenue from Workplace and Health Up 18% —
— Adjusted Gross Margin Was 31.8%, a 40-Basis Point Sequential Expansion —
— Order Rates Up 28%, and Up 35% for Workplace and Health End Markets —
Third Consecutive Quarter of Consistent Double-Digit Workplace and Health Order Growth —
— Reaffirms Full Fiscal Year 2022 Guidance —

JASPER, Ind., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Kimball International, Inc. (NASDAQ: KBAL) today announced results for the second quarter ended December 31, 2021.

Selected Financial Highlights:

Second Quarter FY 2022

  • Net sales of $151.4 million
  • Gross margin of 30.7%; Adjusted gross margin of 31.8%
  • Selling and administrative expenses (S&A) of $51.9 million; Adjusted S&A of $48.5 million
  • Net loss of $21.3 million; Adjusted net loss of $5.7 million
  • Diluted EPS of $(0.58); Adjusted diluted EPS was $(0.16)
  • Adjusted EBITDA of $4.0 million
  • Backlog of $196.9 million

Management Commentary

CEO Kristie Juster commented, “Demand for Kimball International products remained strong in the second quarter, driving double-digit, year-on-year revenue growth. Our Workplace and Health end markets accounted for 89% of second quarter revenues and posted combined revenue growth of 18%. Order rates continued to be robust, driving record backlog levels, which support our expectations for strong second half performance and underpin our confidence in our full year guidance.

“Revenue and order growth was broad-based across most of our key Workplace and Health verticals. Ancillary products that are the cornerstones of the new-forming collaboration and culture-focused workplace environment, accounted for 85% of second quarter sales. Shipments to smaller metropolitan areas that are primary markets for our products, represented 81% of second quarter sales. We did, however, experience continued supply chain disruption and inventory availability issues that affected Poppin’s in stock business model. These factors particularly impacted sales at Poppin, causing a pause in the positive sequential momentum in sales, which we expect to resume in the second half of this fiscal year.

“Our industry continues to experience supply chain and labor issues that have increased costs and constrained our ability to produce and ship. Despite these issues, we were able to deliver an adjusted gross margin that improved 40 bps sequentially. We expect improving operating conditions and additional price increases on orders booked in calendar 2021 to result in expanded gross and EBITDA margins as we convert strong demand into greater increases in revenue and profitability.”

Overview

Second Quarter Fiscal 2022 Results

Consolidated net sales increased 11% to $151.4 million from the year ago quarter led by continued strength in the Workplace and Health verticals and the addition of the Poppin business. Adjusted gross margin increased 40 basis points sequentially to 31.8% while declining from 33.5% in the second quarter of fiscal 2021, and continued to be pressured by raw material inflation and higher freight and labor costs, partially offset by price increases and ongoing cost saving programs. Adjusted selling and administrative expenses (S&A) of $48.5 million, or 32.0% of net sales, declined $0.1 million sequentially while increasing from $40.7 million in last year’s second quarter. Net loss was $21.3 million, or $0.58 per diluted share, inclusive of a $34.1 million non-cash goodwill impairment charge associated with the Poppin acquisition and attributable primarily to the near-term impact of the COVID-19 pandemic. This goodwill impairment reflects our revised assumptions about the near-term operating performance, however, we still believe in the value of both Poppin’s core business model as well as our PoppinPro distribution channel. The impact of these charges was offset partially by a non-cash contingent earn-out benefit of $22.5 million. Adjusted net loss was $5.7 million, or $0.16 per diluted share. Adjusted EBITDA was $4.0 million compared to $9.1 million in the year ago quarter.

Net Sales by End Market            
  Three Months Ended       Six Months Ended    
(Unaudited) December 31,       December 31,    
(Amounts in Millions)   2021     2020   % Change     2021     2020   % Change
Workplace * $ 106.1   $ 87.4   21 %   $ 213.2   $ 182.7   17 %
Health   28.5     27.0   6 %     53.1     47.6   12 %
Hospitality   16.8     21.8   (23 %)     41.7     53.8   (22 %)
Total Net Sales $ 151.4   $ 136.2   11 %   $ 308.0   $ 284.1   8 %


Orders Received by End Market            
  Three Months Ended       Six Months Ended    
(Unaudited) December 31,       December 31,    
(Amounts in Millions)   2021     2020   % Change     2021     2020   % Change
Workplace * $ 123.8   $ 87.1   42 %   $ 239.0   $ 166.6   43 %
Health   30.9     27.4   13 %     60.5     49.7   22 %
Hospitality   17.9     20.4   (12 %)     50.9     58.5   (13 %)
Total Orders $ 172.6   $ 134.9   28 %   $ 350.4   $ 274.8   28 %

* Workplace end market includes education, government, commercial, and financial vertical markets and eBusiness

Summary and Outlook

“We are pleased with the strong year-to-date demand we have experienced across our product portfolio, geographies, and vertical markets, which underscores the relevance of Kimball International’s innovative product designs that provide the flexibility and adaptability needed in today’s workplace.

“Consistently strong order rates in our Workplace and Health markets have resulted in a record backlog heading into the second half of fiscal 2022. Thus, we reaffirm our fiscal 2022 guidance for 15-20% revenue growth with adjusted gross margin in the third quarter similar to first half levels, followed by greater expansion in the fourth quarter as we benefit from higher volumes, price increases and ongoing efficiency projects. As previously noted, we expect to continue to invest in growth during fiscal 2022 by opening and scaling new Poppin showrooms in Miami, Austin and Atlanta, maintaining our commitment and focus around new product initiatives such as EverySpace, and continuing investment in our selling organization.”

Third Quarter FY 2022 Guidance Ranges
  Low High
Revenue growth (year-over-year) 23% 25%
Adjusted gross margin Approx. 31%
Adjusted S&A $50 million $52 million

Non-GAAP Financial Measures

This press release contains non-GAAP financial measures. A non-GAAP financial measure is a numerical measure of a company’s financial performance that excludes amounts so as to be different than the most directly comparable measure calculated and presented in accordance with Generally Accepted Accounting Principles (“GAAP”) in the United States in the statements of income, statements of comprehensive income, balance sheets, or statements of cash flows of the Company. The non-GAAP financial measures used within this release are (1) organic net sales, defined as net sales excluding acquisition-related net sales; (2) adjusted gross profit; (3) adjusted selling and administrative expense; (4) adjusted EBITDA; (5) adjusted operating income; (6) adjusted net income; and (7) adjusted diluted earnings per share. Adjusted operating income, adjusted net income, and adjusted diluted earnings per share each exclude restructuring expense, CEO transition costs, acquisition-related amortization and inventory valuation adjustments, goodwill impairment, contingent earn-out adjustments related to the acquisition, COVID vaccine incentive costs, costs of acquisition, and statutory income tax impacts for taxable after-tax measures, from the GAAP income measure. Adjusted gross profit excludes acquisition-related inventory adjustments and COVID vaccine incentive costs from the GAAP income measure. Adjusted selling and administrative expense excludes market value adjustments related to the SERP liability, CEO transition costs, acquisition-related amortization, costs of acquisition, and COVID vaccine incentive costs from the GAAP income measure. Additionally, adjusted operating income excludes market value adjustments related to the SERP liability. Adjusted EBITDA is defined as earnings before interest, income taxes, depreciation expense, amortization expense, restructuring expense, CEO transition costs, acquisition-related inventory valuation adjustments, costs of acquisition, goodwill impairment, contingent earn-out adjustments related to the acquisition, and COVID vaccine incentive costs. A reconciliation of the reported GAAP numbers to the non-GAAP financial measures is included in the Reconciliation of Non-GAAP Financial Measures table below. Management believes that Adjusted EBITDA and other metrics excluding restructuring expense, CEO transition expenses, market value adjustments related to the SERP liability, COVID vaccine incentive costs and acquisition-related adjustments are useful measurements to assist investors in comparing our performance over various reporting periods on a consistent basis by removing from operating results the impact of items that do not reflect our core operating performance.

The orders received metric is a key performance indicator used to evaluate general sales trends and develop future operating plans. Orders received represent firm orders placed by our customers during the current quarter which are expected to be recognized as revenue during current or future quarters. The orders received metric is not intended to be presented as an alternative measure of revenue recognized in accordance with GAAP.

Forward-Looking Statements

This document may contain certain forward-looking statements about the Company, such as discussions of Company’s pricing trends, liquidity, new business results, expansion plans, anticipated expenses and planned schedules. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. These statements generally can be identified by the use of words or phrases, including, but not limited to, “intend,” “anticipate,” “believe,” “estimate,” “project,” “target,” “plan,” “expect,” “setting up,” “beginning to,” “will,” “should,” “would,” “resume” or similar statements. We caution that forward-looking statements are subject to known and unknown risks and uncertainties that may cause the Company’s actual future results and performance to differ materially from expected results including, but not limited to, the possibility that any of the anticipated benefits of the transaction between the Company and Poppin will not be realized or will not be realized within the expected time period; the risk that integration of the operations of Poppin with the Company will be materially delayed or will be more costly or difficult than expected; the effect of the announcement of the Poppin transaction, including on customer relationships and operating results; the risk that any projections or guidance by the Company, including revenues, margins, earnings, or any other financial results are not realized; adverse changes in global economic conditions; successful execution of Phase 2 of the Company restructuring plan; the impact on the Company of changes in tariffs; increased global competition; significant reduction in customer order patterns; loss of key suppliers; loss of or significant volume reductions from key contract customers; financial stability of key customers and suppliers; relationships with strategic customers and product distributors; availability or cost of raw materials, components and freight; changes in the regulatory environment; global health concerns (including the impact of the COVID-19 outbreak); or similar unforeseen events. Additional cautionary statements regarding other risk factors that could have an effect on the future performance of the Company are contained in the Company’s Form 10-K filing for the fiscal year ended June 30, 2021 and other filings with the Securities and Exchange Commission.

Conference Call / Webcast
     
Date:   February 3, 2022
Time:   5:00 PM Eastern Time
Dial-In #:   1 800-773-2954 (International Calls - 1 847-413-3731)
Pass Code:   50245049

A webcast of the live conference call may be accessed by visiting Kimball International’s Investor Relations website at www.ir.kimballinternational.com.

For those unable to participate in the live webcast, the call will be archived at www.ir.kimballinternational.com within two hours of the conclusion of the live call.

About Kimball International, Inc.

Kimball International is a leading omnichannel commercial furnishings company with deep expertise in the Workplace, Health and Hospitality markets. We combine our bold entrepreneurial spirit, a history of craftsmanship and today’s design-driven thinking alongside a commitment to our culture of caring and lasting connections with our customers, shareholders, employees and communities.

For over 70 years, our brands have seized opportunities to customize solutions into personalized experiences, turning ordinary spaces into meaningful places. Our family of brands includes Kimball, National, Etc., Interwoven, Kimball Hospitality, D’style and Poppin.

Kimball International is based in Jasper, Indiana.

www.kimballinternational.com

Financial highlights for the second quarter ended December 31, 2021 are as follows:

Condensed Consolidated Statements of Income              
(Unaudited) Three Months Ended
(Amounts in Thousands, except per share data) December 31, 2021   December 31, 2020
Net Sales $ 151,403     100.0 %   $ 136,197     100.0 %
Cost of Sales   104,959     69.3 %     90,648     66.6 %
Gross Profit   46,444     30.7 %     45,549     33.4 %
Selling and Administrative Expenses   51,921     34.3 %     45,967     33.7 %
Contingent Earn-Out (Gain) Loss   (22,510 )   (14.8 %)     0     0.0 %
Restructuring Expense   1,010     0.7 %     1,616     1.2 %
Goodwill Impairment   34,118     22.5 %     0     0.0 %
Operating Income (Loss)   (18,095 )   (12.0 %)     (2,034 )   (1.5 %)
Other Income, net   477     0.4 %     1,409     1.0 %
Income (Loss) Before Taxes on Income   (17,618 )   (11.6 %)     (625 )   (0.5 %)
Provision (Benefit) for Income Taxes   3,696     2.5 %     213     0.1 %
Net Income (Loss) $ (21,314 )   (14.1 %)   $ (838 )   (0.6 %)
               
Earnings (Loss) Per Share of Common Stock:              
Basic $ (0.58 )       $ (0.02 )    
Diluted $ (0.58 )       $ (0.02 )    
               
Average Number of Total Shares Outstanding:              
Basic   36,749           36,962      
Diluted   36,749           36,962      


               
(Unaudited) Six Months Ended
(Amounts in Thousands, except per share data) December 31, 2021   December 31, 2020
Net Sales $ 308,013     100.0 %   $ 284,141   100.0 %
Cost of Sales   212,472     69.0 %     186,236   65.5 %
Gross Profit   95,541     31.0 %     97,905   34.5 %
Selling and Administrative Expenses   102,080     33.1 %     87,654   30.9 %
Contingent Earn-Out (Gain) Loss   (17,900 )   (5.8 %)     0   0.0 %
Restructuring Expense   2,465     0.8 %     5,856   2.1 %
Goodwill Impairment   34,118     11.1 %     0   0.0 %
Operating Income (Loss)   (25,222 )   (8.2 %)     4,395   1.5 %
Other Income, net   43     0.0 %     2,226   0.8 %
Income (Loss) Before Taxes on Income   (25,179 )   (8.2 %)     6,621   2.3 %
Provision (Benefit) for Income Taxes   1,184     0.4 %     2,073   0.7 %
Net Income (Loss) $ (26,363 )   (8.6 %)   $ 4,548   1.6 %
               
Earnings (Loss) Per Share of Common Stock:              
Basic $ (0.72 )       $ 0.12    
Diluted $ (0.72 )       $ 0.12    
               
Average Number of Total Shares Outstanding:              
Basic   36,785           36,968    
Diluted   36,785           37,465    


  (Unaudited)    
Condensed Consolidated Balance Sheets December 31,
2021
  June 30,
2021
(Amounts in Thousands)  
ASSETS      
Cash and cash equivalents $ 16,323   $ 24,336
Receivables, net   52,802     58,708
Inventories   72,137     54,291
Prepaid expenses and other current assets   23,404     22,012
Property and Equipment, net   91,772     90,623
Right of use operating lease assets   12,611     14,654
Goodwill   47,844     81,962
Other Intangible Assets, net   61,604     64,478
Deferred Tax Assets   16,229     16,368
Other Assets   17,190     17,163
Total Assets $ 411,916   $ 444,595
       
LIABILITIES AND SHAREHOLDERS’ EQUITY      
Current maturities of long-term debt   33     30
Accounts payable   57,722     41,537
Customer deposits   36,685     24,438
Current portion of operating lease liability   6,237     6,590
Dividends payable   3,620     3,532
Accrued expenses   31,563     39,115
Long-term debt, less current maturities   40,046     40,079
Long-term operating lease liability   10,720     12,536
Long-term earn-out liability   2,290     20,190
Other   16,336     16,878
Shareholders’ Equity   206,664     239,670
Total Liabilities and Shareholders’ Equity $ 411,916   $ 444,595


Condensed Consolidated Statements of Cash Flows Six Months Ended
(Unaudited) December 31,
(Amounts in Thousands)   2021       2020  
Net Cash Flow provided by Operating Activities $ 12,620     $ 24,521  
Net Cash Flow used for Investing Activities   (11,313 )     (105,774 )
Net Cash Flow (used for) provided by Financing Activities   (9,649 )     32,456  
Net Decrease in Cash, Cash Equivalents, and Restricted Cash   (8,342 )     (48,797 )
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period   25,727       92,444  
Cash, Cash Equivalents, and Restricted Cash at End of Period $ 17,385     $ 43,647  


Reconciliation of Non-GAAP Financial Measures              
(Unaudited)              
(Amounts in Thousands, except per share data)              
               
Organic Net Sales        
  Three Months Ended   Six Months Ended
  December 31,   December 31,
    2021     2020     2021     2020
Net Sales, as reported $ 151,403   $ 136,197   $ 308,013   $ 284,141
Less: Poppin acquisition net sales   13,494     2,678     28,718     2,678
Organic Net Sales $ 137,909   $ 133,519   $ 279,295   $ 281,463


Adjusted Gross Profit        
  Three Months Ended   Six Months Ended
  December 31,   December 31,
    2021       2020       2021       2020  
Gross Profit, as reported $ 46,444     $ 45,549     $ 95,541     $ 97,905  
Add: Pre-tax COVID vaccine incentive   1,569       0       1,569       0  
Add: Pre-tax Acquisition-related Inventory Valuation Adjustment   62       42       205       42  
Adjusted Gross Profit $ 48,075     $ 45,591     $ 97,315     $ 97,947  
Adjusted Gross Profit %   31.8 %     33.5 %     31.6 %     34.5 %
               
Adjusted Selling and Administrative Expense        
  Three Months Ended   Six Months Ended
  December 31,   December 31,
    2021       2020       2021       2020  
Selling and Administrative Expense, as reported $ 51,921     $ 45,967     $ 102,080     $ 87,654  
Less: Pre-tax Expense Adjustment to SERP Liability   (680 )     (1,381 )     (587 )     (2,139 )
Less: Pre-tax CEO Transition Costs   0       (141 )     0       (282 )
Less: Pre-tax Acquisition-related Amortization   (1,610 )     (395 )     (3,220 )     (395 )
Less: Pre-tax Costs of Acquisition   0       (3,388 )     0       (3,388 )
Less: Pre-tax COVID Vaccine incentive   (1,140 )     0       (1,140 )     0  
Adjusted Selling and Administrative Expense $ 48,491     $ 40,662     $ 97,133     $ 81,450  
Adjusted Selling and Administrative Expense %   32.0 %     29.9 %     31.5 %     28.7 %
         
Adjusted Operating Income (Loss)        
  Three Months Ended   Six Months Ended
  December 31,   December 31,
    2021       2020       2021       2020  
Operating Income (Loss), as reported $ (18,095 )   $ (2,034 )   $ (25,222 )   $ 4,395  
Add: Pre-tax Restructuring Expense   1,010       1,616       2,465       5,856  
Add: Pre-tax Goodwill Impairment   34,118       0       34,118       0  
Add: Pre-tax Expense Adjustment to SERP Liability   680       1,381       587       2,139  
Add: Pre-tax CEO Transition Costs   0       141       0       282  
Add: Pre-tax Acquisition-related Amortization   1,610       395       3,220       395  
Add: Pre-tax Acquisition-related Inventory Valuation Adjustment   62       42       205       42  
Add: Pre-tax Costs of Acquisition   0       3,388       0       3,388  
Add: Pre-tax Contingent Earn-Out (Gain) Loss   (22,510 )     0       (17,900 )     0  
Add: Pre-tax COVID vaccine incentive   2,709       0       2,709       0  
Adjusted Operating Income (Loss) $ (416 )   $ 4,929     $ 182     $ 16,497  
Adjusted Operating Income (Loss) %   (0.3 %)     3.6 %     0.1 %     5.8 %
               
Adjusted Net Income (Loss)        
  Three Months Ended   Six Months Ended
  December 31,   December 31,
    2021       2020       2021       2020  
Net Income (Loss), as reported $ (21,314 )   $ (838 )   $ (26,363 )   $ 4,548  
               
Pre-tax Restructuring Expense   1,010       1,616       2,465       5,856  
Tax on Restructuring Expense   (259 )     (416 )     (634 )     (1,508 )
Add: After-tax Restructuring Expense   751       1,200       1,831       4,348  
Pre-tax Goodwill Impairment   34,118       0       34,118       0  
Tax on Goodwill Impairment   0       0       0       0  
Add: After-tax Goodwill Impairment   34,118       0       34,118       0  
Pre-tax CEO Transition Costs   0       141       0       282  
Tax on CEO Transition Costs   0       (36 )     0       (72 )
Add: After-tax CEO Transition Costs   0       105       0       210  
Pre-tax Acquisition-related Amortization   1,610       395       3,220       395  
Tax on Acquisition-related Amortization   (414 )     (102 )     (829 )     (102 )
Add: After-tax Acquisition-related Amortization   1,196       293       2,391       293  
Pre-tax Acquisition-related Inventory Valuation Adjustment   62       42       205       42  
Tax on Acquisition-related Inventory Valuation Adjustment   (16 )     (11 )     (53 )     (11 )
Add: After-tax Acquisition-related Inventory Adjustment   46       31       152       31  
Pre-tax Costs of Acquisition   0       3,388       0       3,388  
Tax on Costs of Acquisition   0       (872 )     0       (872 )
Add: After-tax Costs of Acquisition   0       2,516       0       2,516  
Pre-tax Contingent Earn-Out (Gain) Loss   (22,510 )     0       (17,900 )     0  
Tax on Contingent Earn-Out (Gain) Loss   0       0       0       0  
Add: After-tax Contingent Earn-Out (Gain) Loss   (22,510 )     0       (17,900 )     0  
Pre-tax COVID Vaccine Incentive   2,709       0       2,709       0  
Tax on COVID Vaccine Incentive   (697 )     0       (697 )     0  
Add: After-tax COVID Vaccine Incentive   2,012       0       2,012       0  
Adjusted Net Income (Loss) $ (5,701 )   $ 3,307     $ (3,759 )   $ 11,946  
               
               
Adjusted Diluted Earnings (Loss) Per Share        
  Three Months Ended   Six Months Ended
  December 31,   December 31,
    2021       2020       2021       2020  
Diluted Earnings (Loss) Per Share, as reported $ (0.58 )   $ (0.02 )   $ (0.72 )   $ 0.12  
Add: After-tax Restructuring Expense   0.02       0.03       0.05       0.12  
Add: After-tax Goodwill Impairment   0.93       0.00       0.93       0.00  
Add: After-tax Acquisition-related Amortization   0.03       0.01       0.07       0.01  
Add: After-tax Acquisition-related Inventory Valuation Adjustment   0.00       0.00       0.01       0.00  
Add: After-tax Costs of Acquisition   0.00       0.07       0.00       0.07  
Add: After-tax Contingent Earn-Out (Gain) Loss   (0.61 )     0.00       (0.49 )     0.00  
Add: After-tax COVID Vaccine Incentive   0.05       0.00       0.05       0.00  
Adjusted Diluted Earnings (Loss) Per Share $ (0.16 )   $ 0.09     $ (0.10 )   $ 0.32  

        

Adjusted EBITDA        
           
  Three Months Ended   Six Months Ended
  December 31,   December 31,
    2021       2020       2021       2020  
Net Income (Loss) $ (21,314 )   $ (838 )   $ (26,363 )   $ 4,548  
Provision for Income Taxes   3,696       213       1,184       2,073  
Income (Loss) Before Taxes on Income   (17,618 )     (625 )     (25,179 )     6,621  
Interest Expense   275       58       532       86  
Interest Income   (43 )     (87 )     (52 )     (189 )
Depreciation   3,623       3,536       7,185       7,128  
Amortization   2,415       1,049       4,854       1,702  
Pre-tax Restructuring Expense   1,010       1,616       2,465       5,856  
Pre-tax Goodwill Impairment   34,118       0       34,118       0  
Pre-tax CEO Transition Costs   0       141       0       282  
Pre-tax Acquisition-related Inventory Valuation Adjustment   62       42       205       42  
Pre-tax Costs of Acquisition   0       3,388       0       3,388  
Pre-tax Contingent Earn-Out (Gain) Loss   (22,510 )     0       (17,900 )     0  
Pre-tax COVID Vaccine Incentive   2,709       0       2,709       0  
Adjusted EBITDA $ 4,041     $ 9,118     $ 8,937     $ 24,916  
Adjusted EBITDA %   2.7 %     6.7 %     2.9 %     8.8 %


Supplementary Information              
Components of Other Income, net Three Months Ended   Six Months Ended
(Unaudited) December 31,   December 31,
(Amounts in Thousands)   2021       2020       2021       2020  
Interest Income $ 43     $ 87     $ 52     $ 189  
Interest Expense   (275 )     (58 )     (532 )     (86 )
Gain on Supplemental Employee Retirement Plan Investments   680       1,381       587       2,139  
Other Non-Operating Income (Expense)   29       (1 )     (64 )     (16 )
Other Income, net $ 477     $ 1,409     $ 43     $ 2,226  

 

Investor Contacts:
Lynn Morgen lynn.morgen@advisiry.com 
Eric Prouty eric.prouty@advisiry.com 

Kimball International
1600 Royal Street
Jasper, IN 47546
Telephone 812.482.1600


Primary Logo

Source: Kimball International, Inc.